Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Overland Park, Kansas 66211


Purpose:

This trial is conducted in the United States of America (USA). The purpose of this trial is to investigate the dose response to recombinant factor VIIa in healthy volunteers when administered for bleed.


Criteria:

Inclusion Criteria: - Ages Eligible for Study: 18 Years - 60 Years Exclusion Criteria:


NCT ID:

NCT00104455


Primary Contact:

Study Director
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S


Backup Contact:

N/A


Location Contact:

Overland Park, Kansas 66211
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.